Thatch, a platform that helps employers manage healthcare benefits through individual plan marketplaces, raised $108 million at a $1 billion valuation this week. The round came from existing investors The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz, and values the company at more than double its $410 million Series B from just 17 months ago.
Why a benefits platform hit a billion-dollar valuation
The straightforward answer is timing. Employer healthcare costs are projected to jump over 8% in 2027, the largest single-year increase since 2003. Companies are desperate for alternatives to the traditional group plan model, where they negotiate annually with insurers like Anthem or United Healthcare and absorb whatever rate increases come back. Thatch offers a different structure, and the market is ready for it.
Thatch grew its annual recurring revenue roughly seven times since the Series B, according to CEO Chris Ellis. That growth rate, in a sector that usually moves slowly, is what drove the valuation leap. The company is not an AI startup at its core, but it uses AI to recommend the right health plan for each employee based on their specific needs, and that recommendation engine is a meaningful part of the product.
How ICHRA changes the employer healthcare model
Thatch is built on a federal regulation from 2020 called the Individual Coverage Health Reimbursement Arrangement, or ICHRA, which recently rebranded as CHOICE. The regulation lets companies set a fixed health budget for each worker instead of enrolling everyone in one company-wide plan. Employees use those pre-tax funds to choose among dozens of health, dental, and vision plans on Thatch's marketplace.
The model flips the traditional dynamic. Instead of employers negotiating with carriers and employees taking whatever they get, employees choose their own plans and insurers compete for their business. Workers who need extensive care can supplement their allowance out of pocket for comprehensive coverage. Healthier workers can opt for lower-cost plans and use leftover funds via a Thatch debit card for expenses like GLP-1 drugs, the weight-loss and diabetes medications such as Ozempic and Wegovy that traditional plans rarely cover.
For employers, the pitch is simpler: stop renegotiating with carriers every year. Set a budget, let employees choose, and get the same or better coverage at a predictable cost. Ellis says the arrangement creates natural pressure on insurers to improve service and stop denying claims, because employees can switch plans if they are unhappy.
The competitive landscape
Thatch is not alone in this space. Take Command, Remodel Health, and Zorro are all building similar ICHRA-based platforms for employers. The regulation is six years old, but adoption has accelerated as costs have surged and awareness has grown.
What separates Thatch, according to Ellis, is the marketplace experience and the AI-driven plan recommendations. Employees do not just get a list of options. They get guidance on which plan fits their situation, which is critical when the number of available plans runs into the dozens.
The $108 million raise gives Thatch capital to expand its marketplace, deepen its AI capabilities, and compete for larger employer contracts as the ICHRA model gains traction. With healthcare costs continuing to climb and more employers looking for alternatives to traditional group plans, the market Thatch is targeting is growing whether the company executes well or not. The question is whether Thatch can maintain its lead as larger players and more competitors enter the space.